LA JOLLA, Calif., May 18 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that it has further expanded the Company's executive team with the addition of Pratik Multani, M.D., M.S., as Vice President of Clinical Development. With more than a decade of clinical development experience, Dr.

PolyMedix, Inc. (OTC BB: PYMX) announced today that it has appointed Dr. R. Eric McAllister as Vice President, Clinical Development and Chief Medical Officer. R. Eric McAllister, M.D., Ph.D. has joined PolyMedix as Vice President of Clinical Development and Chief Medical Officer. Dr.